Loading…

Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study

Background Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation exi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of headache and pain 2021-03, Vol.22 (1), p.13-6, Article 13
Main Authors: Rustichelli, Cecilia, Bellei, Elisa, Bergamini, Stefania, Monari, Emanuela, Lo Castro, Flavia, Baraldi, Carlo, Tomasi, Aldo, Ferrari, Anna
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43
cites cdi_FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43
container_end_page 6
container_issue 1
container_start_page 13
container_title Journal of headache and pain
container_volume 22
creator Rustichelli, Cecilia
Bellei, Elisa
Bergamini, Stefania
Monari, Emanuela
Lo Castro, Flavia
Baraldi, Carlo
Tomasi, Aldo
Ferrari, Anna
description Background Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. Methods Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. Results Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P  = 0.0328; pregnanolone: P  = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R 2  = 0.1369; P  = 0.0482) and age (R 2  = 0.2826, P  = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R 2  = 0.04436, P  = 0.4337, linear regression analysis). Conclusion Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment.
doi_str_mv 10.1186/s10194-021-01231-9
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4810e6def3b248a093bc5a3395dc4483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4810e6def3b248a093bc5a3395dc4483</doaj_id><sourcerecordid>2504163615</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEoqXwBzggS1wJ-DOOOSChFR-VKnGBszWJJ9usvHawk5b9LfxZTLMs9MLJ9sw7z4xHb1U9Z_Q1Y23zJjPKjKwpZzVlXLDaPKjOGeOm5kLrh6d7Y86qJznvKOVUtOpxdSaEVlpydl793MT9BGnMMZA4kCnhNmCIPgYkefEDzPhqjcIxCsERzHMCN0ZPPN6gz6TD-RYxkAnmEcOcye04X5M9hiJcwPtDndAXliP7cZtgPHL6GOYUfX5bXgR_TD4mmGM6kDwv7vC0ejSAz_jseF5U3z5--Lr5XF99-XS5eX9V90rSuW6M5qgF74cORQeUDkCVFo0G3TptuOzlwCiKRqm20dwJCa1yAhFog9hLcVFdrlwXYWenNO4hHWyE0d4FYtpaSPPYe7SyLaTG4SA6LlugRnS9AiGMcr2UrSisdytrWro9ur4sI4G_B72fCeO13cYbq01rKG8L4OURkOL3pSza7uKSQvm_5YpK1oiGqaLiq6pPMeeEw6kDo_a3OexqDlvMYe_MYU0pevHvbKeSP24oArEKckmFLaa_vf-D_QXi2coI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2504163615</pqid></control><display><type>article</type><title>Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>PubMed Central</source><creator>Rustichelli, Cecilia ; Bellei, Elisa ; Bergamini, Stefania ; Monari, Emanuela ; Lo Castro, Flavia ; Baraldi, Carlo ; Tomasi, Aldo ; Ferrari, Anna</creator><creatorcontrib>Rustichelli, Cecilia ; Bellei, Elisa ; Bergamini, Stefania ; Monari, Emanuela ; Lo Castro, Flavia ; Baraldi, Carlo ; Tomasi, Aldo ; Ferrari, Anna</creatorcontrib><description>Background Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. Methods Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. Results Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P  = 0.0328; pregnanolone: P  = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R 2  = 0.1369; P  = 0.0482) and age (R 2  = 0.2826, P  = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R 2  = 0.04436, P  = 0.4337, linear regression analysis). Conclusion Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment.</description><identifier>ISSN: 1129-2369</identifier><identifier>EISSN: 1129-2377</identifier><identifier>DOI: 10.1186/s10194-021-01231-9</identifier><identifier>PMID: 33757421</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>17β-Estradiol ; Age ; Aged ; Allosteric properties ; Cognitive ability ; Enzyme-linked immunosorbent assay ; Estradiol ; Estrogens ; Female ; Glutamic acid receptors (ionotropic) ; Headache ; Humans ; Internal Medicine ; Liquid chromatography ; Mass spectroscopy ; Medicine ; Medicine &amp; Public Health ; Menstrually-related migraine ; Menstruation ; Migraine ; Migraine Disorders ; N-Methyl-D-aspartic acid receptors ; Neurology ; Neurosteroid ; Neurosteroids ; Pain Medicine ; Pregnanolone ; Pregnenolone ; Pregnenolone sulfate ; Serum levels ; Short Report ; Steroids ; γ-Aminobutyric acid A receptors</subject><ispartof>Journal of headache and pain, 2021-03, Vol.22 (1), p.13-6, Article 13</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43</citedby><cites>FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43</cites><orcidid>0000-0001-9536-3995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2504163615/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2504163615?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33757421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rustichelli, Cecilia</creatorcontrib><creatorcontrib>Bellei, Elisa</creatorcontrib><creatorcontrib>Bergamini, Stefania</creatorcontrib><creatorcontrib>Monari, Emanuela</creatorcontrib><creatorcontrib>Lo Castro, Flavia</creatorcontrib><creatorcontrib>Baraldi, Carlo</creatorcontrib><creatorcontrib>Tomasi, Aldo</creatorcontrib><creatorcontrib>Ferrari, Anna</creatorcontrib><title>Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study</title><title>Journal of headache and pain</title><addtitle>J Headache Pain</addtitle><addtitle>J Headache Pain</addtitle><description>Background Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. Methods Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. Results Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P  = 0.0328; pregnanolone: P  = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R 2  = 0.1369; P  = 0.0482) and age (R 2  = 0.2826, P  = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R 2  = 0.04436, P  = 0.4337, linear regression analysis). Conclusion Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment.</description><subject>17β-Estradiol</subject><subject>Age</subject><subject>Aged</subject><subject>Allosteric properties</subject><subject>Cognitive ability</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Estradiol</subject><subject>Estrogens</subject><subject>Female</subject><subject>Glutamic acid receptors (ionotropic)</subject><subject>Headache</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Liquid chromatography</subject><subject>Mass spectroscopy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Menstrually-related migraine</subject><subject>Menstruation</subject><subject>Migraine</subject><subject>Migraine Disorders</subject><subject>N-Methyl-D-aspartic acid receptors</subject><subject>Neurology</subject><subject>Neurosteroid</subject><subject>Neurosteroids</subject><subject>Pain Medicine</subject><subject>Pregnanolone</subject><subject>Pregnenolone</subject><subject>Pregnenolone sulfate</subject><subject>Serum levels</subject><subject>Short Report</subject><subject>Steroids</subject><subject>γ-Aminobutyric acid A receptors</subject><issn>1129-2369</issn><issn>1129-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1v1DAQhiMEoqXwBzggS1wJ-DOOOSChFR-VKnGBszWJJ9usvHawk5b9LfxZTLMs9MLJ9sw7z4xHb1U9Z_Q1Y23zJjPKjKwpZzVlXLDaPKjOGeOm5kLrh6d7Y86qJznvKOVUtOpxdSaEVlpydl793MT9BGnMMZA4kCnhNmCIPgYkefEDzPhqjcIxCsERzHMCN0ZPPN6gz6TD-RYxkAnmEcOcye04X5M9hiJcwPtDndAXliP7cZtgPHL6GOYUfX5bXgR_TD4mmGM6kDwv7vC0ejSAz_jseF5U3z5--Lr5XF99-XS5eX9V90rSuW6M5qgF74cORQeUDkCVFo0G3TptuOzlwCiKRqm20dwJCa1yAhFog9hLcVFdrlwXYWenNO4hHWyE0d4FYtpaSPPYe7SyLaTG4SA6LlugRnS9AiGMcr2UrSisdytrWro9ur4sI4G_B72fCeO13cYbq01rKG8L4OURkOL3pSza7uKSQvm_5YpK1oiGqaLiq6pPMeeEw6kDo_a3OexqDlvMYe_MYU0pevHvbKeSP24oArEKckmFLaa_vf-D_QXi2coI</recordid><startdate>20210323</startdate><enddate>20210323</enddate><creator>Rustichelli, Cecilia</creator><creator>Bellei, Elisa</creator><creator>Bergamini, Stefania</creator><creator>Monari, Emanuela</creator><creator>Lo Castro, Flavia</creator><creator>Baraldi, Carlo</creator><creator>Tomasi, Aldo</creator><creator>Ferrari, Anna</creator><general>Springer Milan</general><general>Springer Nature B.V</general><general>BMC</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9536-3995</orcidid></search><sort><creationdate>20210323</creationdate><title>Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study</title><author>Rustichelli, Cecilia ; Bellei, Elisa ; Bergamini, Stefania ; Monari, Emanuela ; Lo Castro, Flavia ; Baraldi, Carlo ; Tomasi, Aldo ; Ferrari, Anna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>17β-Estradiol</topic><topic>Age</topic><topic>Aged</topic><topic>Allosteric properties</topic><topic>Cognitive ability</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Estradiol</topic><topic>Estrogens</topic><topic>Female</topic><topic>Glutamic acid receptors (ionotropic)</topic><topic>Headache</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Liquid chromatography</topic><topic>Mass spectroscopy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Menstrually-related migraine</topic><topic>Menstruation</topic><topic>Migraine</topic><topic>Migraine Disorders</topic><topic>N-Methyl-D-aspartic acid receptors</topic><topic>Neurology</topic><topic>Neurosteroid</topic><topic>Neurosteroids</topic><topic>Pain Medicine</topic><topic>Pregnanolone</topic><topic>Pregnenolone</topic><topic>Pregnenolone sulfate</topic><topic>Serum levels</topic><topic>Short Report</topic><topic>Steroids</topic><topic>γ-Aminobutyric acid A receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rustichelli, Cecilia</creatorcontrib><creatorcontrib>Bellei, Elisa</creatorcontrib><creatorcontrib>Bergamini, Stefania</creatorcontrib><creatorcontrib>Monari, Emanuela</creatorcontrib><creatorcontrib>Lo Castro, Flavia</creatorcontrib><creatorcontrib>Baraldi, Carlo</creatorcontrib><creatorcontrib>Tomasi, Aldo</creatorcontrib><creatorcontrib>Ferrari, Anna</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of headache and pain</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rustichelli, Cecilia</au><au>Bellei, Elisa</au><au>Bergamini, Stefania</au><au>Monari, Emanuela</au><au>Lo Castro, Flavia</au><au>Baraldi, Carlo</au><au>Tomasi, Aldo</au><au>Ferrari, Anna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study</atitle><jtitle>Journal of headache and pain</jtitle><stitle>J Headache Pain</stitle><addtitle>J Headache Pain</addtitle><date>2021-03-23</date><risdate>2021</risdate><volume>22</volume><issue>1</issue><spage>13</spage><epage>6</epage><pages>13-6</pages><artnum>13</artnum><issn>1129-2369</issn><eissn>1129-2377</eissn><abstract>Background Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. Methods Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. Results Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P  = 0.0328; pregnanolone: P  = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R 2  = 0.1369; P  = 0.0482) and age (R 2  = 0.2826, P  = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R 2  = 0.04436, P  = 0.4337, linear regression analysis). Conclusion Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment.</abstract><cop>Milan</cop><pub>Springer Milan</pub><pmid>33757421</pmid><doi>10.1186/s10194-021-01231-9</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9536-3995</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1129-2369
ispartof Journal of headache and pain, 2021-03, Vol.22 (1), p.13-6, Article 13
issn 1129-2369
1129-2377
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4810e6def3b248a093bc5a3395dc4483
source Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; PubMed Central
subjects 17β-Estradiol
Age
Aged
Allosteric properties
Cognitive ability
Enzyme-linked immunosorbent assay
Estradiol
Estrogens
Female
Glutamic acid receptors (ionotropic)
Headache
Humans
Internal Medicine
Liquid chromatography
Mass spectroscopy
Medicine
Medicine & Public Health
Menstrually-related migraine
Menstruation
Migraine
Migraine Disorders
N-Methyl-D-aspartic acid receptors
Neurology
Neurosteroid
Neurosteroids
Pain Medicine
Pregnanolone
Pregnenolone
Pregnenolone sulfate
Serum levels
Short Report
Steroids
γ-Aminobutyric acid A receptors
title Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A10%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20pregnenolone%20sulfate,%20pregnanolone%20and%20estradiol%20levels%20between%20patients%20with%20menstrually-related%20migraine%20and%20controls:%20an%20exploratory%20study&rft.jtitle=Journal%20of%20headache%20and%20pain&rft.au=Rustichelli,%20Cecilia&rft.date=2021-03-23&rft.volume=22&rft.issue=1&rft.spage=13&rft.epage=6&rft.pages=13-6&rft.artnum=13&rft.issn=1129-2369&rft.eissn=1129-2377&rft_id=info:doi/10.1186/s10194-021-01231-9&rft_dat=%3Cproquest_doaj_%3E2504163615%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-6972e732cfbe3ba00fa057367a78d7924c4f10e36558672d34a85d3eea06eec43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2504163615&rft_id=info:pmid/33757421&rfr_iscdi=true